Children’s Healthcare of Atlanta and Emory University participated in a nationwide clinical trial showing that a 16-week course of omalizumab, an injectable drug, increased the amount of peanut, tree nuts, egg, milk and wheat that some multi-food allergic children as young as one year could consume without an allergic reaction after exposure.
Tag: Epinephrine
86.4 % de los bebés con anafilaxia recibieron epinefrina de manera adecuada
Un nuevo estudio que se presentó en la Reunión Científica Anual del ACAAI de este año muestra que de los bebés de 0 a 24 meses que acudieron al servicio de urgencias por anafilaxia, pocos requirieron hospitalización y la mayoría pudo irse a casa después de unas horas de observación.
Study Shows 86.4% of Infants with Anaphylaxis Appropriately Received Epinephrine
A new study being presented at this year’s ACAAI Annual Scientific Meeting shows that, in infants aged 0-24 months who presented to the emergency department for anaphylaxis, few required hospitalization and most were able to go home after a few hours of observation.
Solo al 52 % de los adultos con alergia grave a los alimentos se le ha prescrito un autoinyector de epinefrina
Un nuevo estudio que se presenta en la Reunión científica anual del ACAAI muestra que solo la mitad de los pacientes adultos alérgicos a los alimentos tienen acceso inmediato a la epinefrina y que el 36 % de los adultos creen que los autoinyectores de epinefrina pueden causar efectos negativos o potencialmente mortales.
Only 52% of Adults with Severe Food Allergy Have Been Prescribed an Epinephrine Auto Injector
A new study being presented at this year’s ACAAI Annual Scientific Meeting shows that only half of food allergic adult patients have immediate access to epinephrine, and 36% of adults believe epinephrine auto injectors can cause negative or life-threatening effects.